Search

Shirley V. Gembeh

Examiner (ID: 11999, Phone: (571)272-8504 , Office: P/1628 )

Most Active Art Unit
1615
Art Unit(s)
1628, 1615, 1614, 1618
Total Applications
2053
Issued Applications
1120
Pending Applications
147
Abandoned Applications
807

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16390978 [patent_doc_number] => 20200331919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio [patent_app_type] => utility [patent_app_number] => 16/918772 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918772 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/918772
Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio Jun 30, 2020 Abandoned
Array ( [id] => 17850363 [patent_doc_number] => 20220280404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => HAIR COSMETIC [patent_app_type] => utility [patent_app_number] => 17/625474 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625474 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625474
Hair cosmetic Jun 30, 2020 Issued
Array ( [id] => 18018934 [patent_doc_number] => 20220370433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => METHOD FOR PRODUCING ACTIVE AGENT ADMINISTERING SYSTEMS BY MEANS OF PAD PRINTING PROCESSES [patent_app_type] => utility [patent_app_number] => 17/622531 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622531 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/622531
Method for producing active agent administering systems by means of pad printing processes Jun 25, 2020 Issued
Array ( [id] => 19929716 [patent_doc_number] => 12302906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => Feed stuff for beneficial organisms that can be used in integrated pest management [patent_app_type] => utility [patent_app_number] => 17/631659 [patent_app_country] => US [patent_app_date] => 2020-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 0 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631659 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/631659
Feed stuff for beneficial organisms that can be used in integrated pest management Jun 25, 2020 Issued
Array ( [id] => 17836439 [patent_doc_number] => 20220273744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => Process and Apparatus for Production of a Granular Cannabinoid Material Essentially Soluble in Aqueous Medium [patent_app_type] => utility [patent_app_number] => 17/629867 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629867 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/629867
Process and apparatus for production of a granular cannabinoid material essentially soluble in aqueous medium Jun 22, 2020 Issued
Array ( [id] => 16581410 [patent_doc_number] => 20210015812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => Methods for Treating Antipsychotic-Induced Weight Gain [patent_app_type] => utility [patent_app_number] => 16/899708 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899708 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899708
Methods for treating antipsychotic-induced weight gain Jun 11, 2020 Issued
Array ( [id] => 17161698 [patent_doc_number] => 11147780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-19 [patent_title] => Multidrug pain management package [patent_app_type] => utility [patent_app_number] => 16/899465 [patent_app_country] => US [patent_app_date] => 2020-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 13281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899465 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899465
Multidrug pain management package Jun 10, 2020 Issued
Array ( [id] => 17760184 [patent_doc_number] => 20220233796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT [patent_app_type] => utility [patent_app_number] => 17/617853 [patent_app_country] => US [patent_app_date] => 2020-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617853 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617853
METHOD FOR CHARGING A CONTAINER FOR USE WITH A MEDICATION DELIVERY APPARATUS, CONTAINER FOR SUCH AN APPARATUS AND METHOD FOR TREATING A PATIENT Jun 7, 2020 Abandoned
Array ( [id] => 17881159 [patent_doc_number] => 20220296636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => Carbon Monoxide as a Treatment for Neurodegenerative Disease [patent_app_type] => utility [patent_app_number] => 17/616110 [patent_app_country] => US [patent_app_date] => 2020-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/616110
Carbon monoxide as a treatment for neurodegenerative disease Jun 4, 2020 Issued
Array ( [id] => 16839342 [patent_doc_number] => 20210147354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 16/891898 [patent_app_country] => US [patent_app_date] => 2020-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13103 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891898 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/891898
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION Jun 2, 2020 Abandoned
Array ( [id] => 16877960 [patent_doc_number] => 11028093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors [patent_app_type] => utility [patent_app_number] => 16/890663 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 412 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890663 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/890663
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Jun 1, 2020 Issued
Array ( [id] => 16451091 [patent_doc_number] => 20200360517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => NUTRITIONAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/881597 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/881597
Nutritional composition May 21, 2020 Issued
Array ( [id] => 16296136 [patent_doc_number] => 20200281859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => ANHYDROUS DASATINIB-CONTAINING PREPARATION [patent_app_type] => utility [patent_app_number] => 16/879408 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5986 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879408 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/879408
Anhydrous dasatinib-containing preparation May 19, 2020 Issued
Array ( [id] => 18201238 [patent_doc_number] => 11583611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Biocompatible phase invertible proteinaceous compositions and methods for making and using the same [patent_app_type] => utility [patent_app_number] => 16/878061 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6696 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878061 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878061
Biocompatible phase invertible proteinaceous compositions and methods for making and using the same May 18, 2020 Issued
Array ( [id] => 17799017 [patent_doc_number] => 11413283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Topical formulations for delivery of hedgehog inhibitor compounds and use thereof [patent_app_type] => utility [patent_app_number] => 16/878301 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 23679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878301 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878301
Topical formulations for delivery of hedgehog inhibitor compounds and use thereof May 18, 2020 Issued
Array ( [id] => 17910422 [patent_doc_number] => 20220312816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => PREPARATION FOR USE IN ENHANCING FORMATION OF SHORT-CHAIN FATTY ACIDS (SCFAS) [patent_app_type] => utility [patent_app_number] => 17/612755 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612755 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612755
Preparation for use in enhancing formation of short-chain fatty acids (SCFAs) May 17, 2020 Issued
Array ( [id] => 16282753 [patent_doc_number] => 20200276355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/875543 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875543
Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them May 14, 2020 Issued
Array ( [id] => 16282754 [patent_doc_number] => 20200276356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/875554 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875554 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875554
Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them May 14, 2020 Issued
Array ( [id] => 20156922 [patent_doc_number] => 12383520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-12 [patent_title] => Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder [patent_app_type] => utility [patent_app_number] => 17/610366 [patent_app_country] => US [patent_app_date] => 2020-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/610366
Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder May 11, 2020 Issued
Array ( [id] => 20491523 [patent_doc_number] => 12533378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Treatment of adverse effects caused by atypical antipsychotics [patent_app_type] => utility [patent_app_number] => 17/995581 [patent_app_country] => US [patent_app_date] => 2020-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 3197 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995581 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995581
Treatment of adverse effects caused by atypical antipsychotics May 9, 2020 Issued
Menu